Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 203.47M | $ 10.94M | 5.38% |
3/31/2025 | $ 201.35M | $ 11.82M | 5.87% |
12/31/2024 | $ 198.77M | $ 12.43M | 6.25% |
9/30/2024 | $ 190.86M | $ 12.84M | 6.73% |
6/30/2024 | $ 182.02M | $ 13.01M | 7.15% |
3/31/2024 | $ 177.6M | $ 13.27M | 7.47% |
12/31/2023 | $ 192.64M | $ 14.04M | 7.29% |
9/30/2023 | $ 211.85M | $ 14.55M | 6.87% |
6/30/2023 | $ 238.35M | $ 15.27M | 6.41% |
3/31/2023 | $ 256.69M | $ 15.85M | 6.18% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for VANDA PHARMACEUTICALS INC is calculated as follows: SB Comp. [ $ 13.82M ] / Revenues [ $ 241.44M ]
(=) SB Comp % [ 5.72% ]
Minimum
Mar 31, 2021
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 2.99K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |